Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis

Symptomatic treatment of myasthenia gravis is based on the use of peripherally-acting acetylcholinesterase (AChE) inhibitors that, in some cases, must be discontinued due to the occurrence of a number of side-effects. Thus, new AChE inhibitors are being developed and investigated for their potential...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Molecules
المؤلفون الرئيسيون:	Carles Galdeano, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Manuela Bartolini, Belén Pérez, M. Victòria Clos, Israel Silman, Ludovic Jean, Jacques-Philippe Colletier, Pierre-Yves Renard, Diego Muñoz-Torrero
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2018-03-01
الموضوعات:	acetylcholinesterase inhibitors butyrylcholinesterase inhibitors quinolinium compounds triazoles structural biology copper-catalyzed azide-alkyne cycloaddition click chemistry
الوصول للمادة أونلاين:	http://www.mdpi.com/1420-3049/23/3/634